INTRODUCTION {#s1}
============

In recent years, the traditional view that the heart is a terminally differentiated organ with no capacity for cardiomyocyte renewal has been emphatically refuted by an increasing number of studies in humans and other mammals \[[@R1]--[@R3]\]. Several studies have found that 1-day-old neonatal mice were capable of undergoing cardiac regeneration following multiple types of cardiac injury, but the ability to efficiently regenerate heart muscle was lost by postnatal day 7 \[[@R4]--[@R6]\]. Further study by our group examined the global gene expression patterns of the neonatal mouse heart at key time points (1 and 7 days old) \[[@R7]\] and found several differentially expressed genes involved in transient regeneration of the neonatal mouse heart. However, there is limited original data regarding cardiac regeneration during this developmental period.

Long noncoding RNAs (lncRNAs) are defined as transcripts greater than 200 nt without a known protein-coding function \[[@R8]\]. There is increasing evidence that lncRNAs can regulate gene expression at the epigenetic, transcription, and post-transcription levels and participate in a range of biological processes \[[@R9]\]. A recent study showed that many lncRNAs are expressed in the heart and confirmed the essential role of lncRNAs in the cardiovascular system such as modulating cardiac development \[[@R10]\]. Further studies have shown that lncRNAs are involved in coronary artery disease \[[@R11]\] and myocardial hypertrophy \[[@R12]\]. In addition, some lncRNAs have been found to be involved in cardiac regeneration. For example, lncRNA-ST8SIA3 (also named lncRNA ROR, regulator of reprogramming) enhances the reprogramming of fibroblasts to become induced pluripotent stem cells or cardiomyocytes \[[@R13]\]. Knocking out the gene lncRNA-H19 has been shown to promote differentiation of parthenogenetic embryonic stem cells to cardiomyocytes with strong heart-like beating \[[@R14]\]. However, our understanding of the role of lncRNAs in regeneration of heart tissue in mice is still limited. Therefore, two key time points (1 and 7 days old) were selected for the analysis of global lncRNA expression profiles in C57BL/6 mice using next-generation high-throughput RNA sequencing techniques.

RESULTS {#s2}
=======

Profiles of the differently expressed lncRNAs and mRNAs {#s2_1}
-------------------------------------------------------

From the lncRNA expression profiles, 685 differentially expressed lncRNAs in mouse cardiac tissue were compared between P1 and P7. Compared to 1-day-old cardiac tissue, we identified 418 downregulated lncRNAs and 267 upregulated lncRNAs in 7-day-old cardiac tissue. As shown in Figure [1A](#F1){ref-type="fig"}, these lncRNAs showed a general difference between P1 and P7. 32 lncRNAs exhibited a high fold change of at least 3-fold, where 9 lncRNAs exhibited increased expression and 23 lncRNAs decreased expression (Supplementary Material). The the 685 differentially expressed lncRNAs in mouse cardiac tissue were list in the supplementary materials.

![Hierarchical clustering of the differentially expressed LncRNAs and mRNAs in murine cardiac tissue in postnatal days 1 and 7 (P1 and P7)\
(**A**) Differentially expressed LncRNAs; (**B**) Differentially expressed mRNAs. Yellow indicates upregulation; blue indicates downregulation.](oncotarget-08-28052-g001){#F1}

From the analysis of sequencing data, 1833 differentially expressed mRNAs were found with comparisons between 1-day-old and 7-day-old cardiac tissue, among which 859 were upregulated mRNAs and 974 were downregulated mRNAs in 7-day-old cardiac tissue compared with tissue from 1-day-old mice. Their distinct expression patterns are also presented in the hierarchical clustering analysis shown in Figure [1B](#F1){ref-type="fig"}.

Genomic location of differentially expressed lncRNAs {#s2_2}
----------------------------------------------------

Length of the lncRNAs was generally between 400 bp and 3600 bp (Figure [2A](#F2){ref-type="fig"}, [2B](#F2){ref-type="fig"}). Chromosomal distribution showed the numbers of up- and downregulated lncRNAs located on different chromosomes (Figure [2C](#F2){ref-type="fig"}, [2D](#F2){ref-type="fig"}). Chromosomal distribution showed the upregulated lncRNAs were mainly located on chromosome 14, 1 and 6, and the downregulated lncRNAs were mainly located on chromosome 17, 9, 6 and 7. The functional characterisation of these lncRNAs presents a formidable task, and some studies suggest that lncRNAs regulate higher-order chromosomal dynamics, sub-cellular structural organisation and telomere biology \[[@R19]\]. LncRNAs have been suggested to originate from complex loci that include lncRNA and associated protein-coding genes, since several lncRNAs have been reported to regulate the expression of adjacent protein-coding genes \[[@R20], [@R21]\]. Such information about these lncRNAs and their nearby coding genes might be useful to predict their functional roles in heart regeneration (Table [1](#T1){ref-type="table"}).

![(**A**) Length distribution of the upregulated lncRNAs. (**B**) Length distribution of the downregulated lncRNAs. The upregulated and downregulated lncRNAs are mainly between 400 and 3600 bp in length. (**C**) Chromosome distribution shows the numbers of upregulated lncRNAs located in different chromosomes; chr represents chromosome. (**D**) The numbers of downregulated lncRNAs located in different chromosomes.](oncotarget-08-28052-g002){#F2}

###### lncRNAs and their nearby coding genes

  Transcript           Upstream second gene   Upstream first gene   Downstream first gene   Downstream second gene
  -------------------- ---------------------- --------------------- ----------------------- ------------------------
  fantom3_B430306C15   fantom3_9230114P20     Slc10a6               1700016H13Rik           fantom3_F830205C23
  NR_033497            fantom3_4930408C10     fantom3_A830009F23    Myh7                    fantom3_D330040O14
  fantom3_G630025L12   Kctd6                  Acox2                 fantom3_C630031G01      Fam107a
  fantom3_D330013N04   fantom3_A330004D21     Myl4                  Itgb3                   fantom3_7030418D15
  fantom3_B230377K03   Mt3                    fantom3_A830083K16    Mt2                     fantom3_1810074C23
  fantom3_1110003P13   2700060E02Rik          fantom3_8030491K24    Gng2                    fantom3_C130093P08
  fantom3_4930408C10   Myh6                   Mir208a               fantom3_A830009F23      D830015G02Rik
  fantom3_9530030H05   Oxnad1                 fantom3_2410002F01    Msmb                    Ncoa4
  NR_033813            fantom3_A330045P15     Begain                Meg3                    fantom3_I0C0047O18
  fantom3_2310031C01   Fam47e                 fantom3_D530019K15    Stbd1                   Ccdc158
  fantom3_D530019K15   fantom3_C730043O17     Fam47e                fantom3_2310031C01      Stbd1
  fantom3_2510038C20   Mt2                    fantom3_1810074C23    Mt1                     Nup93
  fantom3_1810074C23   fantom3_B230377K03     Mt2                   fantom3_2510038C20      Mt1
  NR_030416            fantom3_I0C0030C13     fantom3_1100001A04    fantom3_D130045N19      Igf2
  NR_001592            fantom3_9530074L01     fantom3_9830166K08    fantom3_I0C0030C13      fantom3_1100001A04
  fantom3_I0C0030C13   fantom3_9830166K08     H19                   fantom3_1100001A04      Mir675
  fantom3_1100001A04   H19                    fantom3_I0C0030C13    Mir675                  fantom3_D130045N19
  fantom3_9830143G06   Tmem164                fantom3_6030487A22    fantom3_4932428A02      fantom3_B230314K16
  fantom3_4932428A02   fantom3_6030487A22     fantom3_9830143G06    fantom3_B230314K16      fantom3_C430013O12
  fantom3_9230118C23   fantom3_D330009G10     2310050B05Rik         fantom3_2310050B05      Nmrk2
  NR_015477            Dapk3                  fantom3_D330009G10    fantom3_9230118C23      fantom3_2310050B05
  fantom3_D330009G10   Snord37                Dapk3                 2310050B05Rik           fantom3_9230118C23
  fantom3_D130045N19   fantom3_1100001A04     Mir675                Igf2                    Mir483
  fantom3_1010001E19   fantom3_B230374I20     fantom3_B230350D20    fantom3_E430001N13      fantom3_D830012D22
  fantom3_D830012D22   fantom3_1010001E19     fantom3_E430001N13    fantom3_0610011H19      fantom3_D030018G08
  fantom3_E430001N13   fantom3_B230350D20     fantom3_1010001E19    fantom3_D830012D22      fantom3_0610011H19
  fantom3_G730023M12   fantom3_A730057F09     Stc2                  fantom3_F830230J18      Bod1
  fantom3_4930578O05   fantom3_4930558J22     Hist1h4b              Hist1h4a                Hist1h3a
  fantom3_A830073O21   Gm4971                 fantom3_A730020G15    Fam174b                 fantom3_4932443D20
  fantom3_2310024F14   fantom3_A730026F12     Fxyd6                 Fxyd2                   fantom3_1700101G12
  fantom3_A630066O12   Ank1                   fantom3_6330529I17    Mir486                  Mir3107
  NR_039592            fantom3_E030018F15     Kctd12                fantom3_4933432I03      4933432I03Rik
  fantom3_D630044L13   fantom3_F930015M13     Mir3966               fantom3_9530076L14      Dcn
  fantom3_1700119I11   Zcchc9                 Ckmt2                 fantom3_6430599K20      fantom3_D830014B08
  fantom3_C130052N24   Stard4                 fantom3_E230006P11    Nrep                    fantom3_D930015L03
  fantom3_D830028G10   Lrtm1                  fantom3_A930039P05    fantom3_D130049P09      fantom3_B930020O18
  fantom3_A230064C13   Crhr1                  Sppl2c                Mapt                    Kansl1
  fantom3_2210409C20   Itgb6                  fantom3_E030019H01    fantom3_F420008A03      fantom3_I920190L12
  fantom3_2310015A16   Sik1                   fantom3_C130051M16    fantom3_C130017E03      Hsf2bp
  fantom3_B230352I09   fantom3_C230086B22     fantom3_4933422O15    fantom3_2010321I05      Tnrc6a

Validation of differentially expressed lncRNAs {#s2_3}
----------------------------------------------

To verify the RNA-Seq data, we randomly selected 22 differentially expressed lncRNAs for qPCR analysis, among which 11 were upregulated lncRNAs and 11 were downregulated lncRNAs in 7-day-old cardiac tissue compared with tissue from 1-day-old mice. The result showed that the expression patterns of those lncRNAs were consistent with the RNA-Seq data (Figure [3](#F3){ref-type="fig"}).

![Comparison between sequencing data and the qRT-PCR result for lncRNAs\
Columns above the X-axis indicate the upregulated lncRNAs, and columns below the X-axis represent the downregulated lncRNAs.-PCR. The validation results indicated that the sequencing data correlated well with the qPCR results.](oncotarget-08-28052-g003){#F3}

GO and pathway analysis {#s2_4}
-----------------------

We performed GO analysis for the coding genes associated with differentially expressed lncRNAs as shown in Figure [4A](#F4){ref-type="fig"}. The top 10 terms associated with biological processes were: (1) GO:0008283: cell proliferation; (2) GO:0030154: cell differentiation; (3) GO:0042127: regulation of cell proliferation; (4) GO:0044249: cellular biosynthetic process; (5) GO:0019222: regulation of metabolism; (6) GO:0042981: regulation of apoptosis; (7) GO:0016049: cell growth; (8) GO:0060038: cardiac muscle cell proliferation; (9) GO:0007346: regulation of the mitotic cell cycle; and (10) GO:0051726: regulation of the cell cycle.

![GO and pathway analysis\
(**A**) The list of the top 10 GO terms with the associated coding gene function of dysregulated lncRNAs. (**B**) The list of the top 10 pathways associated with the coding gene of dysregulated lncRNAs.](oncotarget-08-28052-g004){#F4}

![The co-expression network of the coding genes comparing P1 and P7, with the highly-dysregulated lncRNAs\
A correlation of \> 0.99, or a correlation \< −0.99 and *P* value of \< 0.05 were recognised as co-expression. Red lines indicate a positive correlation, green lines indicate a negative correlation. (**A**) The co-expression network of the upregulated coding genes. A red circle indicates the upregulated coding genes, and a yellow square indicates lncRNAs. (**B**) The co-expression network of the downregulated coding genes. A green circle indicates the downregulated coding genes, a yellow square indicates LncRNAs.](oncotarget-08-28052-g005){#F5}

We also performed KEGG pathway enrichment analysis for the coding genes associated with differentially expressed lncRNAs. The most significant pathways were: metabolic, tight junctions and signalling pathways including PI3K-Akt, cGMP-PKG, cAMP, MAPK, calcium, adrenergic signalling in cardiomyocytes, Hippo and Wnt (Figure [4B](#F4){ref-type="fig"}).

CNC network {#s2_5}
-----------

Biological networks cover modules of genes or proteins that may function in the same pathway; genes or proteins inside the same module can be co-regulated \[[@R22]\]. Therefore, construction of a CNC network could infer the biological functions of lncRNAs \[[@R22], [@R23]\], which would increase our understanding of the complex molecular mechanisms of heart regeneration.

Our data showed that the downregulated co-expression network was composed of 74 network nodes and 328 connections between 18 lncRNAs and 67 coding genes. The upregulated co-expression network was composed of 51 network nodes and 158 connections between 17 lncRNAs and 43 coding genes. In both of the co-expression networks, there was a positive correlation between most of the pairs. In addition, we observed that one lncRNA could target several coding genes and that one coding gene correlated with several lncRNAs. For example, in the downregulated co-expression network, the downregulated lncRNAs fantom3_B230352I09 and fantom3_1110003P13 were correlated with 17 and 15 coding genes respectively. In the upregulated co-expression network, lncRNA fantom3_2210409C20 and fantom3_G730023M12, upregulated in P7, were co-expressed with 8 and 7 coding genes respectively. By the coding-noncoding gene co-expression network, we identified some correlated targets of highly-dysregulated lncRNAs such as Igfbp3, Trnp1 Itgb6, and Pim3. As shown in Figure [5](#F5){ref-type="fig"}, those lncRNAs with the highest co-expression show the most important position.

DISCUSSION {#s3}
==========

Although various miRNAs \[[@R24]\], transcription factors \[[@R25]\], growth factors \[[@R26]\], and cell cycle regulatory elements \[[@R27], [@R28]\] have been shown to regulate the genes that orchestrate proliferation during the regeneration of cardiomyocytes, the role of lncRNAs is poorly understood. Compared with adult mammals, neonatal mice have full capacity for cardiac regeneration after injury. Therefore, charting the transcriptional profile of lncRNAs in regenerative hearts from neonatal mice is a key step in understanding the role of lncRNAs, and this study was the first to examine the expression of lncRNAs in regenerative hearts.

Using next-generation high-throughput RNA sequencing techniques, this study found 685 lncRNAs that were differentially expressed in the heart between postnatal days 1 and 7 (P1 and P7, respectively), which consisted of 418 downregulated and 267 upregulated lncRNAs. In addition, 1833 differentially expressed mRNAs were identified, consisting of 859 upregulated and 974 downregulated mRNAs. 11 upregulated lncRNAs and 11 downregulated lncRNAs were further validated using qRT-PCR, and the results were consistent with the data of RNAseq. In addition, chromosomal distribution showed the upregulated lncRNAs were mainly located on chromosome 14, 1 and 6, and the downregulated lncRNAs were mainly located on chromosome 17, 9, 6 and 7. Interestingly, the Notch1 located on the chromosome 9 and TBX2 located on the chromosome 17 are closely related to heart development \[[@R29], [@R30]\].

We also used GO and pathway analyses to identify potential biological functions enriched among the associated genes of differentially expressed lncRNAs. GO functional enrichment analysis showed that the coding genes associated with differentially expressed lncRNAs were significantly involved in the following processes: cell proliferation and its regulation, cell differentiation, the cellular biosynthetic process; regulation of metabolism, regulation of apoptosis, cell growth, cardiac muscle cell proliferation and regulation of the mitotic and cell cycles. Stimulating endogenous cardiac regeneration by increasing the cell cycle activity of cardiomyocytes could increase the number of cardiomyocytes in an injured heart \[[@R31]\]. Previous studies have suggested that lncRNAs play a role in cell cycle regulation and cardiac development \[[@R32]--[@R34]\] and therefore that they are involved in cell cycle regulation of cardiomyocytes and cardiac regeneration \[[@R35]\]. Our study provides further evidence of the potential role of differentially expressed lncRNAs in the regenerative potential of heart tissue in neonatal mice, via regulation of the differentially expressed genes associated with differentiation and proliferation of cardiomyocytes.

Pathway-Express analysis identified that the metabolic pathways were most significantly affected by the coding genes associated with differentially expressed lncRNAs in 7-day-old cardiac tissue compared with tissue from 1-day-old mice. Macromolecules including glycogen, proteins, nucleotides and lipids represent both the cellular energy reserve and also the essential building blocks for cell renewal \[[@R36]\]. Neonatal mice retain the capacity for cardiac regeneration, but this is lost after 7 days. Therefore, the demand for the anabolic production of macromolecules in the regenerating heart increases during the first 6 days after birth.

The other significant signalling pathways were thePI3K-Akt, MAPK, Hippo, and adrenergic signalling in cardiomyocytes. Previous studies have shown that MAPK signalling pathways have non-redundant roles in the regulation of zebrafish cardiac regeneration \[[@R37]\]. The PI3K-AKT pathway promotes cardiomyocyte proliferation, survival, and physiological hypertrophy \[[@R38]\], and both the Hippo and Wnt signalling pathways also play an important role in cardiac regeneration \[[@R38]--[@R40]\]. In addition, it has been reported that sympathetic nerves have an important role in neonatal mammalian heart regeneration \[[@R41], [@R42]\]. Therefore, we hypothesised that those differentially expressed lncRNAs might participate in the process of neonatal cardiac regeneration by regulating the associated gene expression targeting these pathways.

To study the biological functions and potential mechanisms of differentially expressed lncRNAs, we constructed a CNC network on the basis of the correlation analysis between the differentially expressed lncRNAs and mRNA. Compared with the conventional differential expression analysis, the co-expression network analysis indicates the higher-order relationships of the transcripts in the biological framework \[[@R43]\]. In our co-expression network, we observed that some lncRNAs expression levels were markedly correlated with the expression of several protein-coding genes, indicating the importance of their location. For instance, the lncRNA fantom3_B230352I09, which was downregulated in P7, was co-expressed with 17 coding genes, most of which were related to apoptosis, cell growth, regulation of the cell cycle and cell proliferation. As another example, the Trnp1 gene \[[@R44]\] has been reported to accelerate cell cycle progression and the Pim3 gene \[[@R45]\] has a cardio-protective effect through the process of anti-apoptosis. Igfbp3 is a downstream target of Wnt signaling pathway and participates in the regulation of adult cardiac progenitor cell regeneration \[[@R46]\]. The lncRNA fantom3_2210409C20, upregulated in P7, was co-expressed with 8 coding genes. Among the co-expressed genes, Itgb6 (a β subunit of integrins) was found to be relatively close to fantom3_2210409C20. Integrins are expressed in all cellular compartments of the cardiovascular system and mediate cell adhesion, migration, proliferation and survival in many cell types \[[@R47]\]. Whether cardiac regeneration in 1-day-old neonatal mice is regulated by these lncRNAs warrants further study. Although our current understanding of lncRNA regulation in cardiac regeneration is in its infancy, several approaches can be employed to investigate their biological functions, including over-expression of lncRNA, lncRNA silencing and structure disruption, which may provide more conclusive evidence to explain the regulatory mechanisms.

In conclusion, we have shown the global different expression profiles of lncRNAs during the first seven days in the neonatal mouse heart. By bioinformatics prediction, we obtained some target genes of the candidate lncRNAs such as Igfbp3, Trnp1 Itgb6, and Pim3, which correlated with the process of proliferation. Collectively, our results suggest that lncRNAs could be important regulators in mammalian cardiac regeneration. Further work is needed to understand the biological functions and molecular mechanisms of specific lncRNAs implicated in cardiac regeneration.

MATERIALS AND METHODS {#s4}
=====================

Animal and tissue preparation {#s4_1}
-----------------------------

The neonatal C57BL/6J mice were purchased from the Model Animal Research Centre of Nanjing University (Nanjing, China). Our study was approved by the Animal Care and Use Committee of Nanjing Medical University (Nanjing, China) and the methods were carried out in accordance with the approved guidelines. The left ventricular apex was removed from neonates 1 and 7 days after birth, cleaned and snap-frozen in liquid nitrogen. Three biological replicates were generated per timepoint. Hearts from five to ten mouse pups were pooled for each biological replicate.

RNA extraction and quality control {#s4_2}
----------------------------------

Total RNA was extracted from neonatal mouse heart tissue using TRIzol reagent (Invitrogen Life Technologies) in accordance with the manufacturer\'s protocol. RNA quantity and quality were measured using a NanoDrop ND-1000. RNA integrity was assessed by standard denaturing agarose gel electrophoresis.

Analysis of sequencing data {#s4_3}
---------------------------

RNA-Seq based transcriptome profiling was performed by the Guangzhou RiboBio Co, using the high-throughput, high-sensitivity HiSeq 3000 sequencing platform (Illumina Company, USA). Clean data were acquired by removing joint sequence fragments, low-quality segments and ribosomal RNA. The short reads were mapped to the reference genome using TopHat \[[@R15]\] with 2 mismatches (−−read-mismatches = 2) and 2 gaps (read-gap-length = 2). Transcripts were assembled and the relative abundance of genes was estimated using Cufflinks in reads per kilobase of transcript per million mapped reads (RPKM) \[[@R16]\]. Differentially expressed lncRNAs between P1 and P7 were identified through fold change as well as *P* values calculated with a *t-test*. The threshold set for dysregulated lncRNAs was a fold change of ≥ 1.0 and a *P value* of ≤ 0.05. A hierarchical clustering analysis was applied to classify lncRNAs based on their expression levels.

Quantitative PCR (qPCR) analysis {#s4_4}
--------------------------------

The results of RNA-Seq were validated via qPCR analysis. The cDNA was generated from 1 μg of total RNA using an AMV Reverse Transcriptase kit (Invitrogen Life Technologies). We designed primers for each lncRNA using Primer 3 (<http://sourceforge.net/projects/primer3/>) and used the Basic Local Alignment Search Tool from NCBI to verify that the amplified product was unique. The qPCR was performed using an ABI 7300 Sequence Detection system (Applied Biosystems, Foster City, CA, USA), under the following conditions: denaturation at 95°C for 10 min, and 40 cycles of 95°C for 15 sec and 60°C for 1 min. Relative gene expression levels were normalised to GAPDH and calculated according to the 2^−ΔCT^ method. Each sample was measured in triplicate and reproduced at least three times. The sequences of the primers used are shown in Table [2](#T2){ref-type="table"}.

###### PCR primer sequences used

  Gene                 Forward primer (5′-3′)   Reverse primer (3′-5′)
  -------------------- ------------------------ -------------------------
  fantom3_E030046K02   CTGGAAGAGAGCACCAGACC     TGGTTTCTCACACCAGACCA
  fantom3_4930408C10   TGGGGAGGAGAGAAAAGGTT     TGTGCCTCTCCCTTTCTGTT
  fantom3_2310031C01   ACTCCCCAAGTGTGCTTTTG     TGTACAGTTCAAGGCTCTGTTTT
  NR_015477            AGCGAGGCCAGCAGTCTAC      GGCCTCAGAATCCATGCTT
  fantom3_C230055E17   AAGCCTCTATGGCAAGCGTA     AAGGCTGACCAAAAGCAGAA
  fantom3_9230118C23   AGGTCCCAAGAGCACAGAGA     CAGGTATGAGGCCCTTGTGT
  fantom3_5830483C05   TGCTGGTCACAAAAGTCAGG     GGTCGGTGGAGGAGTATGAA
  NR_029468            GATTTTTCCGTCTGGTCCAA     CAGGCCGTCTTCTCAGACTC
  NR_038184            CTATCCACCACACCCTGCTT     CCTTCTACATTCCCCACGAA
  fantom3_D330009G10   AGCGAGGCCAGCAGTCTAC      GGCCTCAGAATCCATGCTT
  fantom3_D330040O14   TAGCCAGAGTTGGTGTGCAG     AATGGCTTTGGTGTCTTTGG
  fantom3_9930010F05   TATGCAATACCATGCCCAGA     CTTGGCTCCACTTCAAGAGC
  fantom3_1700119I11   AGCATGGCTAACGGACAGAT     CCCATGATGCAAGATTTCCT
  fantom3_E430001N13   GTACCGCAAGGGAAAGATGA     CCAGCTATCACCAAGCTCGT
  fantom3_A530095I10   CCCTGCCCTGTAATTTTGAA     TATCCGGCTCTGCAAGAAGT
  fantom3_D830038L22   GCTTTGCGTTTTCTGAGTCC     CATCCCTTTGCACTGTCCTT
  fantom3_6430599K20   TTCCTTGGCTCCTAGCAGAA     CTATGCCCTTGTCTGGCAAT
  fantom3_9530076L14   TGCCTACTTCTGCAACACCA     CCCACCCTCACCTCATAGTG
  fantom3_G730023M12   CAAGTGCTGAAGGATGACCA     GCTGGAGAGGCTCAATCATC
  fantom3_D030072M03   AACCAAGGCCAAGATTCCTT     GAGCCAGGCAATGAACAAAT
  fantom3_E130215H24   AGGCAGCGCTCTGAGATAAG     CTGCGGGTGATTTATGTGTG
  fantom3_C130045B11   GGCCTTCTGTTTGTGTGGTT     GCTTTCCACTCTCTGGCATC
  GAPDH                ATTCAACGGCACAGTCAA       CTCGCTCCTGGAAGATGG

GO and pathway analysis {#s4_5}
-----------------------

Gene ontology (GO) analysis provides a controlled vocabulary to describe the molecular actions of gene products, their cellular locations and the biological processes in which those actions occur \[[@R17]\]. Fisher\'s exact test was used to detect any significant overlap between the differentially expressed list and the GO annotation list. The *P* value denotes the significance of GO term enrichment between differentially expressed genes (a *P* value ≤ 0.05 is accepted as significant). Pathway analysis was used to map genes to KEGG pathways. The *P* value (calculated via EASE-score, Fisher *P* value or hypergeometric *P* value) denotes the significance of the pathway correlations (a *P* value of ≤ 0.05 is recommended, since the smaller the *P* value, the greater the significance of the pathway).

Construction of the coding-noncoding gene co-expression network {#s4_6}
---------------------------------------------------------------

The coding-noncoding gene co-expression network (CNC network) was constructed based on the correlation analysis between the differentially expressed lncRNAs and mRNAs. The algorithm has been previously described \[[@R18]\]. Briefly, for each pair of genes analysed, we calculated the Pearson correlation coefficient (PCC) and correlation coefficient of the PCC between lncRNAs and coding genes (lncRNA-mRNA PCC and lncRNA-lncRNA PCC). We subsequently selected lncRNAs and mRNAs based on the PCC using the selection parameter PCC ≥ 0.99 as significant and created the co-expression networks using Cytoscape (Institute of Systems Biology, Seattle, US).

Statistical analysis {#s4_7}
--------------------

The data were analysed using the SPSS 17.0 software package (SPSS, Chicago, IL, USA). Differential expression levels of lncRNAs were compared by independent-samples *t*-test between two groups, and Fisher\'s exact test was used in GO and pathway analysis. All values are expressed as the mean ± standard deviation from three independent experiments, and a *P* value of \< 0.05 was considered statistically significant.

SUPPLEMENTARY MATERIALS FIGURES AND TABLES {#s5}
==========================================

**Authors' contributions**

Ling-Mei Qian and Chun Zhu designed and supervised experiments; Yu-Mei Chen and Hua Li performed all the experiments; Yi Fan prepared animal and tissue and extracted RNA; Qi-Jun Zhang, Xing Li, Li-Jie Wu and Zi-jie Chen contributed to the data analysis; Yu-Mei Chen organized, designed, and wrote the paper; Yu-Mei Chen and Chun Zhu critically revised the manuscript. All authors reviewed the final manuscript.

This study was supported by grants from the National Natural Science Foundation of China (No. 81370278 and No. 81570209) and Nanjing Medical Science and Technique Development Foundation (Ykk15148).

**CONFLICTS OF INTEREST**

The authors declare no competing financial interests.
